Beyond the signaling effect role of amyloid-β42 on the processing of APP, and its clinical implications
- 30 September 2010
- journal article
- comment
- Published by Elsevier BV in Experimental Neurology
- Vol. 225 (1), 51-54
- https://doi.org/10.1016/j.expneurol.2010.04.018
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- The “LEARn” (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer’s disease, and proposes remedial stepsExperimental Gerontology, 2010
- Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factoriesNeurobiology of Aging, 2010
- Signaling effect of amyloid-β42 on the processing of AβPPExperimental Neurology, 2010
- Amyloid β-protein stimulates trafficking of cholesterol and caveolin-1 from the plasma membrane to the Golgi complex in mouse primary astrocytesNeuroscience, 2009
- Disease-Modifying Approach to the Treatment of Alzheimerʼs DiseaseDrugs & Aging, 2009
- Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammationNature, 2009
- Mutant Presenilin 1 Increases the Expression and Activity of BACE1Online Journal of Public Health Informatics, 2009
- A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous systemAnnals of Neurology, 2009
- The transcription factor Yin Yang 1 is an activator of BACE1 expressionJournal of Neurochemistry, 2006
- Putative function of ADAM9, ADAM10, and ADAM17 as APP α-secretaseBiochemical and Biophysical Research Communications, 2003